We report an 89-year-old retired farmer with prolonged bradycardia and hypotension after pyrethroid insecticides ingestion in a suicidal attempt. This patient also had a clinical manifestation mimicking organophosphate poisoning, included confusion, lacrimation and salivation. He required intensive care support, atropine and inotrope infusions treatments. Only metabolites of synthetic pyrethroid insecticides (3-phenoxybenzoic acid and 3-phenoxybenzaldehyde) were detected in the urine sample. In the serum toxicology screening, specific analysis for organophosphate pesticides was negative. He eventually recovered without major sequela. (Hong Kong j.emerg.med. 2016;23:47-51) 89 3-3-
Introduction
Pyrethrins and pyrethroids are commonly used insecticides. Pyrethrins are natural botanical insecticides derived from extracts of the flowers of Chrysanthemum genus, primarily Chrysanthemum cinerariaefolium and coccineum, 1 while pyrethroids are synthetic derivatives of pyrethrins. In contrast to organophosphate insecticide, pyrethroids are less toxic to human. Pyrethroids are 2250 times more toxic to insects than mammals because insects have increased sodium channel sensitivity, smaller body size, and lower body temperature. 1 In addition, mammals are protected by poor dermal absorption and rapid metabolism to non-toxic metabolites. 2 Severe pyrethroid insecticide poisoning is uncommon in the developed world. 3 We describe a patient with severe pyrethroid poisoning, whose clinical presentation mimics organophosphate poisoning. Since treatment and prognosis of organophosphate and pyrethroid poisoning vary, it is very important to identify the culprit poison.
Case report
An 89-year-old retired farmer was brought to the emergency department (ED) for suicidal attempt with ingestion of unknown amount of insecticide in July 2014. He had history of chronic obstructive pulmonary disease and hypertension. His usual medications included amlodipine, theophylline, salbutamol and fluticasone/salmeterol inhalers. Neither the culprit agent nor the container could be identified. The only information available was that it was a locally purchased insecticide. He presented to the hospital about 1 hour post-exposure. At presentation, his blood pressure was 168/70 mmHg with pulse rate 90 beats per minute, respiratory rate 20 breaths per minute, body temperature 36.6 o C and SpO 2 96% on room air. He was drowsy with Glasgow Coma Scale (GCS) score of E2V2M6. He had lacrimation and hypersalivation. Chest examination showed no wheeze. Surface decontamination was performed by removing the contaminated clothes and cleansing the patient's skin with soap water. He was intubated with etomidate and rocuronium for airway protection. Gastric lavage with 6 liters of fluid was instilled. The chest X-ray showed clear lung fields and normal mediastinum. The first electrocardiogram (ECG) showed sinus rhythm, with ventricular ectopics, prolonged corrected QT interval (485 msec) and QRS duration (118 msec) (Figure 1 ). He was given atropine 1.2 mg in view of apparent cholingeric symptoms suggestive of organophosphate poisoning. A single dose of activated charcoal (50 g) was also given.
He was transferred to the intensive care unit (ICU) for further management. Blood tests including arterial blood gas, complete blood count, renal and liver function were unremarkable. He was sedated with low dose of morphine and midazolam infusion. Three hours after admission (6 hours post ingestion), he developed bradycardia with hypotension. His blood pressure dropped to 80/50 mmHg and heart rate 40 beats per minute. ECG showed sinus bradycardia, at a rate 45 beats per minute and corrected QT interval 427 msec ( Figure 2 ). Atropine in total 8.4 mg was administered in an incremental manner. Chest examination revealed no wheeze or crepitation. His hypotension and sinus bradycardia were not responsive to atropine bolus. Atropine infusion at 1-5 mg/min and adrenaline infusion at 10 mcg/min were started. Pralidoxime infusion at 8-10 mg/kg/min was also commenced in view of suspected organophosphate poisoning. Haemodynamics including heart rate gradually improved after 6 hours. Serum pseudocholinesterase levels were normal from day 1 to day 3. Serum pseudocholinesterase, cardiac enzymes and albumin level were listed in Table 1 . Adrenaline, atropine and sedation infusion were weaned off on day 3 and he was extubated on day 4. Pralidoxime was then stopped on day 5.
On day 7, he became confused and developed bradycardia again. His ECG showed sinus bradycardia at a rate of 40 beats per minute with new T wave inversion in anterior leads. His GCS score dropped from 15 to E2V4M5. His blood pressure maintained at 120/50 mmHg. Serum pseudocholinesterase level dropped to 5 kU/L. Pralidoxime and atropine infusions were restarted. His conscious state improved with full GCS score on day 10. Pralidoxime and atropine infusions were then stopped. His condition remained stable and was transferred to general ward on Day 11. Psychiatrist assessed and diagnosed patient with late onset delusional disorder and depression. He was discharged after 12 days of hospitalisation and was put on quetiapine and trihexyphenidyl.
In the urine specimen, naphthalene, as well as 3- 
Discussion
Pyrethroids are widely used insecticides and are considered to have low toxicity to human. Pyrethroids are classified according to its chemical structure and poisoning syndromes. Type I pyrethroids (allethrin, permethrin) have a basic cyclopropane carboxylic ester structure and produce reflex hyperexcitability and fine tremor (T syndrome). Type II pyrethroids (cypermethrin, deltamethrin, fenvalerate) have a cyano group and they produce salivation, hyperexcitability, choreoathetosis and seizures (CS syndrome). 4, 5 Both types produce sympathetic activation. Dermal exposure causes paresthesia of the exposed skin while ingestion results in gastrointestinal irritation. Life threatening toxicities could be resulted from pyrethroid poisoning. Cha et al 6 reported severe toxicities from pyrethroid poisoning including respiratory failure requiring mechanical ventilation, hypotension, acute kidney injury, seizure and even death. Prognostic predictors included ingestion more than 250 ml and serum lactate >3.5 mmol/L.
Both type I and II pyrethroids selectively act on the insect sodium channels. By delaying the closure of the voltage-sensitive sodium channels, pyrethroids prolong the neuronal excitation causing repetitive firing and paresthesia. Type II pyrethroids also decrease chloride currents through voltage-dependent chloride channels and act on GABA-gated chloride channels leading to more severe excitatory effects such as seizures. 7 Organophosphate inhibits acetylcholinesterase and causes excessive acetylcholine action on muscarinic and n i c o t i n i c re c e p t o r s . Mu s c a r i n i c f e a t u re s o f organophosphate poisoning include diarrhoea, urination, miosis, bronchorrhoea, bronchospasm, bradycardia, emesis, lacrimation, salivation ( D U M B E L S ) w h i l e n i c o t i n i c s i g n s i n c l u d e fasciculation, diaphoresis, mydriasis, tachycardia and hypertension. It can also cause pulmonary oedema, arrhythmias, confusion and progress to seizure and death. Intermediate syndrome and long term complications, like organophosphate induced delayed peripheral neuropathies and delayed neuropsychiatric sequelae, are observed.
Our patient initially presented with symptoms mimicking organophosphate poisoning with emesis, lacrimation, salivation, bradycardia with shock and confusion. In fact, patients with pyrethroid poisoning may present with similar clinical features as organophosphate poisoning. There were few reports in literature where patients with pyrethroid poisoning were mistakenly diagnosed as acute organophosphate poisoning. 8 In this case, analysis of biological specimens provided the definitive diagnosis. The analytical platform utilised in this case allowed for analysis of most organophosphate agents used in Hong Kong. As such, a negative result has high negative predictive value in this case.
Our patient had uncommon manifestation of pyrethroid poisoning with prolonged bradycardia as well as hypotension requiring atropine and inotrope infusion. Pyrethroid is well known for its neurotoxicity yet cardiotoxicity is rarely report. In physiological animal study, Spencer et al 9 observed that tefluthrin (type I pyrethroid), fenpropathrin, and cypermethrin (type II pyrethroids) prolonged action potentials and evoked afterdepolarisations in rat and guinea pig cardiac myocytes while tetramethrin (type I pyrethroid) had little effect on heart. This indicated that certain pyrethroids have arrhythmogenic potential. Bhaskar et al 10 reported a case of suicidal poisoning due to prallethrin (type I pyrethroid) induced prolonged sinus arrest with an escape junctional rhythm for 3 days but no neurotoxicity. The authors proposed the mechanism of sinus arrest being the same as that of neurotoxicity i.e. a high influx of sodium preventing further generation of action potential. The prolonged bradycardia in our patient may be explained by the sodium channel blockage action on the sinoatrial node. As only low dose of sedation was given, the persistent bradycardia of the patient was unlikely caused by the sedation infusion. hypoalbuminaemia, 12 malnutrition, renal disease and burn. 13 In our patient, pseudocholinesterase level decreased with albumin level (Table 1 ). The possible cause for the altered mental state in our patient during ICU stay could be delirium due to prolonged sedation and myocardial infarction. Our patient had elevated cardiac enzymes and new ischaemic change in ECG (T wave inversion in anterior leads) at the time of deterioration which might explain the recurrent bradycardia. Other explanation for the recurrent bradycardia could be the residual effect of the pyrethroids.
Although pyrethroids are generally considered less toxic than organophosphates, poisoning with large amount could also be life threatening. Clinical features of pyrethroid poisoning could mimic organophosphate poisoning. Our patient illustrated that severe cardiotoxicity could be resulted from pyrethroid poisoning.
